Nasz Lekarz Osrodek Badan Klinicznych | Torun, Poland

Research site
ul. Batorego 18-22, Torun, Kuyavian-Pomeranian, Poland

Site insights

Top conditions

Top treatments

ABP 654

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 4 total trials

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL (ECHELON-3)

Participants in this study will have diffuse large B-cell lymphoma (DLBCL) that has come back or not gotten better with treatment. The trial will stu...

Active, not recruiting
Diffuse Large B-cell Lymphoma
Drug: Rituximab
Drug: Lenalidomide

This is an open-label, multicentre study too Evaluate the Safety and Pharmacokinetics of a Modified Tafasitamab IV Dosing Regimen Combined with Lenal...

Active, not recruiting
Diffuse Large B Cell Lymphoma
Drug: Lenalidomide
Drug: Tafasitamab

The participants of this study would have relapsed/refractory follicular lymphoma.Follicular lymphoma is a type of blood cancer. It is referred to as...

Relapsed/Refractory Follicular Lymphoma
Follicular Lymphoma
Combination Product: Rituximab
Drug: Placebo oral tablet

Trial sponsors

Amgen logo
Seagen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems